>>> US After Hours Summary: WWD / RMBS +2%, SWFT +1%, CLB -7%, GOOG /


After Hours Summary: WWD / RMBS +2%, SWFT +1%, CLB -7%, GOOG / APC -3% following earnings/guidance, CLLS +6% on patent news

After Hours Gainers:

Companies trading higher in after hours in reaction to earnings/guidance: WWD +2%, MC +1.8% (ticking higher), RMBS +1.7%, CDNS +1.5%, SWFT +1.3%

Companies trading higher in after hours in reaction to news: CLLS +5.6% (granted patent for CRISPR use in CAR T-cells), ATW +4.4% (ticking higher; provides fleet status report as of July 24, 2017), GNCA +2.9% (continued strength), SRCI +1.8% (reports operational update; reaffirms 2017 operated D&C capex of $320-340 mln), JCP +1.2% (light volume; announced that Jeffrey Davis is joining as EVP/CFO effective today)

After Hours Losers:

Companies trading lower in after hours in reaction to earnings/guidance: TISI -21.2% (reports prelim Q2 results, finalizes negotiations of credit facility amendment and terminates At-the-Market equity offering program), SANM -9.2%, CLB -6.9%, GOOG -3.1%, APC -3.1%, HSII -2.9% (light volume), HXL -1.4%

Companies trading lower in after hours in reaction to news: NVAX -17.9% (announces topline data from its Phase 2 safety and immunogenicity trial of the RSV F Vaccine in older adults, new data on RSV F vaccine, and additional findings from prior phase 2 and 3 studies of E201 and E301), MBRX -3.7% (files for $75 mln mixed securities shelf offering), FTI -1.6% (light volume; will restate select financial statements; determined material weakness existed relating to the rates used in calculations of foreign currency effects), MRK -0.9% (Phase 3 Study of KEYTRUDA pembrolizumab monotherapy in patients with previously treated recurrent or metastatic head and neck squamous cell carcinoma did not meet its pre-specified primary endpoint of overall survival)